Description:

ODM derived from http://clinicaltrials.gov/show/NCT00275379

Link:

http://clinicaltrials.gov/show/NCT00275379

Keywords:
Versions (2) ▾
  1. 3/6/12
  2. 6/7/17
Uploaded on:

June 7, 2017

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age 18 Years and older
Subjects seeking medical treatment for symptoms consistent with IC that have been ongoing for > 9 months or seeking medical treatment for a previous documented diagnosis of IC
Subjects who are not surgically sterile or postmenopausal (amenorrheic > 12 months) must agree and commit to the use of a medically acceptable, highly-effective (i.e. double-barrier or IUD), non-hormonal form of birth control during the study and for 30 days after the last dose of test
Exclusion Criteria
Use of herbal supplements (except for a daily multivitamin/mineral supplement not containing herbal components)
History of cancer (other than resected cutaneous basal or squamous cell carcinoma or in situ cervical cancer) with less than 5 years documentation of a disease-free state
Vaginitis or vaginal infection within 1 month before randomization